ITGB2 and neoplasm: Pharmacological activation of MAC-1 using GB1275 (Leukadherin-1), which binds MAC-1 and activates this β2 integrin by outside-in signaling [328], yielded pronounced anti-tumor effects in numerous studies [142,329,330].